Editorial - Journal of Neuroinformatics and Neuroimaging (2025) Volume 10, Issue 2

Automated Lesion Detection in Stroke Patients Using Deep Convolutional Neural Networks

Department of Neuroscience, Karolinska Institute, Sweden.

Corresponding Author:

Julia Andersson
Department of Neuroscience
Karolinska Institute, Sweden
E-mail: julia.andersson@brainstockholm.se

Received: 03-Jan-2025, Manuscript No. AANN-25-169296; Editor assigned: 04-Jan-2025, PreQC No. AANN-25-1692965(PQ); Reviewed: 18-Jan-2025, QC No AANN-25-1692965; Revised: 21-Jan-2025, Manuscript No. AANN-25-1692965(R); Published: 28-Jan-2025, DOI:10.35841/aann -10.2.190

Citation: Andersson J. Automated lesion detection in stroke patients using deep convolutional neural networks. J NeuroInform Neuroimaging. 2025;10(2):190.

Introduction

Automated lesion detection plays a critical role in the diagnosis, treatment planning, and prognosis assessment of stroke patients. Stroke remains a leading cause of death and long-term disability worldwide, with rapid and accurate detection of brain lesions being essential for timely intervention. Traditional methods for lesion identification rely heavily on expert radiological interpretation of magnetic resonance imaging (MRI) or computed tomography (CT) scans, a process that can be time-consuming, subject to inter-observer variability, and challenging in emergency settings. Deep convolutional neural networks (CNNs) have emerged as powerful tools for automated lesion detection, offering the potential to assist clinicians by providing fast, accurate, and reproducible assessments. These networks excel at learning complex spatial patterns in imaging data, making them particularly suitable for detecting the diverse and often subtle manifestations of stroke-related brain damage [1].

One of the strengths of CNN-based approaches is their ability to perform end-to-end learning, directly mapping raw imaging data to lesion segmentation outputs without the need for handcrafted features. This capability allows CNNs to automatically learn hierarchical representations of image features, from low-level edges and textures to high-level lesion patterns. In the context of stroke, CNNs can be trained on large annotated datasets of diffusion-weighted MRI (DWI), fluid-attenuated inversion recovery (FLAIR) images, or CT scans to detect ischemic or hemorrhagic lesions. Architectures such as U-Net and its variants have become popular in medical image segmentation tasks due to their ability to capture both local and global contextual information. By integrating multi-scale feature extraction with skip connections, these architectures can accurately delineate lesion boundaries even when lesions vary in size, shape, and intensity. Transfer learning techniques can further improve performance by leveraging pretrained networks adapted to medical imaging, reducing the amount of labeled data required [2].

The application of CNNs to automated lesion detection also extends to multimodal imaging integration. Stroke diagnosis often benefits from the combined interpretation of different MRI sequences or CT modalities, each providing complementary information about lesion type and extent. For example, combining DWI with apparent diffusion coefficient (ADC) maps can enhance the detection of acute ischemic lesions, while incorporating FLAIR or susceptibility-weighted imaging (SWI) can aid in identifying older infarcts or hemorrhagic components. CNN architectures designed for multimodal fusion can process multiple imaging inputs in parallel, learning to extract synergistic features that improve lesion detection accuracy. Additionally, temporal imaging data from longitudinal scans can be incorporated to monitor lesion evolution over time, offering potential for prognostic modeling in stroke recovery [3].

Beyond segmentation accuracy, CNN-based systems can also provide clinically relevant lesion metrics, such as lesion volume, location, and overlap with functionally critical brain regions. These quantitative measures are essential for predicting clinical outcomes, guiding rehabilitation strategies, and evaluating treatment efficacy. Integration of lesion detection models into clinical workflows can enable near-real-time decision support in acute stroke management, helping to prioritize patients for interventions such as thrombolysis or mechanical thrombectomy. Moreover, automated lesion detection can facilitate large-scale research studies by enabling rapid and consistent lesion annotation across thousands of scans, accelerating the discovery of imaging biomarkers associated with stroke subtypes and recovery patterns. The scalability and reproducibility of CNN-based approaches make them particularly valuable for multi-center trials and big data neuroimaging initiatives [4].

Despite their promise, several challenges must be addressed before CNN-based automated lesion detection can be fully implemented in routine clinical practice. A major obstacle is the variability in imaging protocols, scanner hardware, and patient populations across different institutions, which can degrade model generalizability. Domain adaptation techniques and harmonization strategies are being explored to mitigate these effects. Additionally, the scarcity of large, high-quality annotated datasets remains a bottleneck for training robust models, particularly for rare lesion types or subtle presentations. Another concern is the interpretability of deep learning models, as clinicians may be hesitant to trust predictions without understanding the underlying decision process. Efforts to develop explainable AI methods, such as saliency maps or attention mechanisms, aim to increase transparency and clinician confidence. Finally, regulatory approval, rigorous validation, and integration with picture archiving and communication systems (PACS) are necessary steps to transition these technologies from research prototypes to approved clinical tools [5].

Conclusion

Deep convolutional neural networks offer a powerful and promising approach for automated lesion detection in stroke patients, combining high accuracy with the potential for rapid, scalable analysis. By leveraging advanced architectures, multimodal data integration, and quantitative output generation, CNN-based systems can assist clinicians in diagnosing stroke more efficiently, guiding treatment decisions, and monitoring disease progression. While challenges related to generalizability, data availability, and interpretability remain, ongoing advances in deep learning methodologies, explainable AI, and dataset curation are steadily overcoming these barriers. As these technologies mature and gain regulatory approval, they are likely to become an integral part of stroke imaging workflows, improving both patient outcomes and the efficiency of clinical care.

References

1. Loma I, Heyman RMultiple sclerosis: Pathogenesis and treatment. Curr Neuropharmacol. 2011;9(3):409-16.

Indexed at, Google Scholar, Crossref

2. Miyazaki Y, Niino M, Takahashi E, et al. Stages of brain volume loss and performance in the brief international cognitive assessment for multiple sclerosis. Mult Scler Relat Disord. 2022;67:104183.

Indexed at, Google Scholar, Crossref

3. Gandhi R, Laroni A, Weiner HL. Role of the innate immune system in the pathogenesis of multiple sclerosis. J Neuroimmunol. 2010;221(1-2):7-14.

Indexed at, Google Scholar, Crossref

4. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity. 2008;28(4):454-67.

Indexed at, Google Scholar, Crossref

5. Fujinami RS, von Herrath MG, Christen U, et al. Molecular mimicry, bystander activation, or viral persistence: Infections and autoimmune disease. Clin Microbiol Rev. 2006;19(1):80-94.

Indexed at, Google Scholar, Crossref